Concepedia

Michael Grzelak

MG

9

Publications

522

Citations

9

H-Index

2001

Active since

Affiliations

Johns Hopkins University(Current)

Johns Hopkins Medicine

University of Maryland, Baltimore

Merck & Co., Inc., Rahway, NJ, USA (United States)

Johns Hopkins Hospital

Michael Grzelak is an author at Johns Hopkins University specializing in medicine, pharmacology, and neuroscience.

ORCID

Top concepts

Publications per year

2001–2021

9

Publications

9

Precision genome editing using synthesis-dependent repair of Cas9-induced DNA breaks

Alexandre Paix, Andrew W. Folkmann, Daniel Goldman et al. · Proceedings of the National Academy of Sciences · 2017 · 236 citations · Full text

SCH 57790, a selective muscarinic M2 receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animals

Galen Carey, William Billard, Herbert Binch et al. · European Journal of Pharmacology · 2001 · 76 citations

, , +8

Design and Validation of Bicyclic Iminopyrimidinones As Beta Amyloid Cleaving Enzyme-1 (BACE1) Inhibitors: Conformational Constraint to Favor a Bioactive Conformation

Mihirbaran Mandal, Zhaoning Zhu, Jared N. Cumming et al. · Journal of Medicinal Chemistry · 2012 · 56 citations · Full text

, , +21

Structure-Based Design of an Iminoheterocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE) Inhibitor that Lowers Central Aβ in Nonhuman Primates

Mihirbaran Mandal, Yusheng Wu, Jeffrey Misiaszek et al. · Journal of Medicinal Chemistry · 2016 · 41 citations · Full text

A Skin Rejection Grading System for Vascularized Composite Allotransplantation in a Preclinical Large Animal Model

Joanna W. Etra, Michael Grzelak, Samuel A. J. Fidder et al. · Transplantation · 2019 · 31 citations · Full text

Rows per page

1–5 of 9